Announcements Trials
Browse Landscape

Status

Completed 8Terminated 4Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Bevacizumab 38Capecitabine 17Oxaliplatin 16Irinotecan 15Leucovorin 12HMPL-013 12Fluorouracil 11Cetuximab 10trifluridine tipiracil drug combination 7irinotecan sucrosofate 6tipiracil 5Trifluridine 5Folfox protocol 5Drug Therapy 5tislelizumab 4Standard of Care 4Specimen Handling 4Mitomycin 4trametinib 3toripalimab 3pembrolizumab 3Magnetic Resonance Spectroscopy 3Injections 3IFL protocol 3Colonoscopy 3Blood Specimen Collection 3sotorasib 2sintilimab 2regorafenib 2dehydroftorafur 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Colorectal Neoplasms × Gene Expression Profiling × Clear all
NCT03127111 2022-03-15

Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer

Renmin Hospital of Wuhan University

Not yet recruiting
300 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡